BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Sequencing analysis revealed that the BCR-ABL translocation in these CML-iPSCs expresses the p210 oncoprotein with a typical b3a2 rearrangement and lack of mutations in the kinase domain (Supplementary Fig. S1a and b).